A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...
Psychotropic drugs are all the rage now as a potential treatment of brain diseases. Examples are ketamine and psilocybin for depression and PTSD. More recently, a single dose of LSD was found to have ...
A mid-stage study of a pharmaceutical version of the psychedelic LSD reported the drug might help alleviate anxiety symptoms for up to three months, advancing a potential treatment for the most common ...
A single dose of LSD can cut anxiety in half within weeks, according to the results of a new study conducted by a biopharmaceutical company. MindMed, a clinical-stage company that develops novel ...
Please provide your email address to receive an email when new articles are posted on . NEW YORK — One dose of lysergide produced clinical remission of generalized anxiety disorder as soon as 4 weeks ...
A 100 microgram dose of a pharmaceutical version of the hallucinogenic drug LSD could help stave off the symptoms of severe anxiety for weeks, a study suggests. Experts said the results are ...
Drug overdoses can be life threatening, but for two women who accidentally took massive hits of LSD the experience was life changing -- and in a good way. A 46-year-old woman snorted a staggering 550 ...
(CNN) — A clinical trial’s encouraging results won an LSD formulation approval from the US Food and Drug Administration as a breakthrough therapy for generalized anxiety disorder, Mind Medicine Inc.
(CNN) — A clinical trial’s encouraging results won an LSD formulation approval from the US Food and Drug Administration as a breakthrough therapy for generalized anxiety disorder, Mind Medicine Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results